MedTrace Logo

Multi-Site Feasibility Testing of the Ventricular Assist Device Anticipatory Guidance Tool

NCT06823583 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2025-09-19

No results posted yet for this study

Summary

There are a variety of educational documents available to help in a participant's decision for VAD implant, however there is little information available to potential participants to help understand areas of satisfaction and concern following a VAD implant as various time points. The investigators want to provide better patient care through increased education and awareness beyond surgical outcomes and contribute to patient understanding of "what to expect" following a VAD implant.

The investigators have created an anticipatory guidance (AG) tool based upon previous responses recorded in a local program's database, from the Quality of Life with a Left Ventricular Assist Device (QoLVAD) questionnaire. This questionnaire has five different domains (physical, social, emotional, cognitive thinking and spiritual/well-being). Investigators have previously analyzed responses to determine common areas of satisfaction and concern at 3-, 6-, 12- and 24-months post-VAD implant to better understand quality of life when living with a VAD. Investigators have had both VAD clinicians and VAD patients initially evaluate the tool to determine accuracy and effectiveness of the anticipatory guidance (AG) tool.

Conditions

  • Ventricular Assist Device
  • Advanced Heart Failure
  • Anticipatory Guidance

Sponsors & Collaborators

  • International Consortium of Circulatory Assist Clinicians

    collaborator OTHER

  • International Society for Heart and Lung Transplantation

    collaborator OTHER

  • Bryan Heart

    lead OTHER

Principal Investigators

  • Mathue Baker, MD · Bryan Heart

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-08-17
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06823583 on ClinicalTrials.gov